Axogen Stock News

AxoGen (AXGN) delivered earnings and revenue surprises of 38.46% and 0.11%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

AxoGen (NASDAQ:AXGN) is scheduled to announce Q4 earnings results on Tuesday, February 22nd, after market close.The consensus EPS Estimate is -$0.13 (-62.5% Y/Y) and the consensus

AxoGen (AXGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AxoGen (AXGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ALACHUA, Fla. and TAMPA, Fla., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,

ALACHUA, Fla. and TAMPA, Fla., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, t

ALACHUA, Fla. and TAMPA, Fla., Feb. 02, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,

ALACHUA, Fla. and TAMPA, Fla., Feb. 02, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, t

Axogen (AXGN) expects FY21 revenue of $127.3M (consensus $127.79M), +13% Y/Y.4Q revenue to be $31.5M (consensus $32.05M), -3% Y/Y.4Q revenue includes $0.5M from the reversal of a…

Clinical evidence supporting the company’s platform for nerve repair will be featured in several presentations during the scientific sessions Clinical evidence supporting the company’s platform fo

Analysts expect that AxoGen, Inc. (NASDAQ:AXGN) will post ($0.13) earnings per share (EPS) for the current quarter, Zacks reports. Two analysts have provided estimates for AxoGens earnings. The lowest EPS estimate is ($0.17) and the highest is ($0.09). AxoGen posted earnings of ($0.08) per share in the same quarter last year, which suggests a negative []

Equities research analysts predict that AxoGen, Inc. (NASDAQ:AXGN) will report earnings of ($0.13) per share for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for AxoGens earnings. The lowest EPS estimate is ($0.17) and the highest is ($0.09). AxoGen reported earnings of ($0.08) per share in the same quarter last []

ALACHUA, Fla. and TAMPA, Fla., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, announced today that nerve repair patient Christopher (Chris) Brown has been selected to ride on the 2022 Donate Life Rose Parade Float. Additionally, organ and tissue donor Paul Flanders will be honored through a floragraph that will adorn the float. The parade will be held in Pasadena, CA on New Years Day as part of the annual Tournament of Roses ® celebration. This is the ninth year that Axogen has co-sponsored the Donate Life float to help raise awareness for the importance of organ and tissue donation.

Assenagon Asset Management S.A. lessened its stake in shares of AxoGen, Inc. (NASDAQ:AXGN) by 24.7% in the 3rd quarter, Holdings Channel.com reports. The firm owned 387,524 shares of the medical equipment provider’s stock after selling 127,253 shares during the quarter. Assenagon Asset Management S.A.’s holdings in AxoGen were worth $6,123,000 as of its most recent […]

Cubist Systematic Strategies LLC lowered its stake in AxoGen, Inc. (NASDAQ:AXGN) by 29.8% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 5,058 shares of the medical equipment providers stock after selling 2,143 shares during the quarter. Cubist Systematic Strategies LLCs holdings in AxoGen []